Panelists discuss how emerging, better-tolerated oral therapies for idiopathic pulmonary fibrosis (IPF) and progressive ...

In July 2020, Monjuvi in combination with lenalidomide received FDA approval for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise ...

Key takeaways: A four-drug combination administered early may be a better strategy for treating diabetic kidney disease than the usual care. The GOLD-STANDARD trial is designed to test this ...

Combination therapies for chronic lymphocytic leukemia (CLL) offer improved depth of response and potentially longer survival times compared with single-agent treatments. They target different ...

The AI platform pinpointed a list of female-biased combinations (e.g. Y-27632/SB-203580/SD-208) that were more effective in addressing AVS in female cells, while AI-optimised male-biased combinations ...

Researchers successfully blended various combinations and proportions of three solvent-free alkyl-π room-temperature liquids that fluoresced red, green, or blue light, with no color variation ...

Jose Silva traveled more than 1,500 miles to celebrate Father’s Day this year. Silva’s 18-year-old son, also named Jose Silva, is in his first year playing shortstop for the Frederick Keys ...

Incyte Announces FDA Approval of Monjuvi® (tafasitamab-cxix) in Combination with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma - Monjuvi® (tafasitamab ...

The recent approval of garadacimab can help to treat patients with hereditary angioedema (HAE) along with sebetralstat, which is awaiting FDA approval, explains Timothy Craig, DO, Penn State Health.

For players who can put two enchantments on one item, these are the best combinations when enchanting weapons.

A new study led by Keck Medicine of USC researchers may have uncovered an effective combination therapy for glioblastoma, a brain tumor diagnosis with few available effective treatments. According ...

President Trump’s trade war is likely to lead to higher prices and slower growth, a challenging combination for the Fed. War in the Middle East could make the job harder still.